Sun, Dec 21, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Private Equity Strategies

3i Acquires A&A Manufacturing After a Round of Successful Exits

Tuesday, September 02, 2014

3i Group plc, alongside management, has agreed to acquire A&A Manufacturing, a leading manufacturer of engineered, mission critical protective equipment. 3i is investing approximately $110 million. The enterprise value of the transaction, which is subject to customary closing conditions, is $202.5 million.

The announcement comes after a round of successful exits for the firm, which has been taking full advantage of the frothy financing and exit markets.

Headquartered in New Berlin, Wisconsin, A&A’s products are made from a variety of materials ranging from composites to exotic metals. The products are designed to protect and elongate the life of valuable machinery while promoting worker safety by keeping crucial equipment functioning properly. Since its establishment in 1945, A&A has grown to be a market-leading global manufacturer of niche engineered protective and safety equipment, primarily for various industrial applications. The Company has manufacturing operations in North America and Germany and sales throughout the world; it employs 474 staff globally and generated revenues of approximately $91 million in 2013.

3i has invested in similar companies in the sector including MoldMasters, Hilite, Hyva and NORMA. The firm recently exited its investment in Hilite for a return of 2.1x.

In sterling terms, the total proceeds to 3i Group and funds represented a 2.1x money multiple on the original investment of €190 million (£172 million). Proceeds to 3i Group from the transaction were £155 million, representing a 32% uplift against a value of £117m at 31 December 2013 and a 17% uplift against a value of £133 million at 31 March 2014.

The sector represents a favorite investment thesis of the firm, and one that has attracted repeat attention from LPs. 3i is a public company traded in London, one of a handful of private equity firms that have decided to go public themselves in recent years.

“A&A is a great business and we look forward to working with the management team to help accelerate its expansion into international markets.” said Ken Hanau, Managing Partner, 3i North America.

 
This article was published in Opalesque's Private Equity Strategies our monthly research update on the global private equity landscape including all sectors and market caps.
Private Equity Strategies
Private Equity Strategies
Private Equity Strategies
Private Equity Strategies


Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. Opalesque Exclusive: U.S. legal receivables fund launched in August[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: Investing in asset-backed receivables is a strategy that has been an integral part of the alternative investment space within the overall fixed income asset c

  5. Comment - High fees and low performance hit hedge funds[more]

    From FT.com: Disenchantment over high fees and lackluster performance may finally be turning the tide against hedge funds, fresh data suggest. Despite generally weak returns since the global financial crisis, hedge funds have enjoyed positive net inflows every year since 2010. This helped assets und